The tissue and organ transplantation market involves the transplantation of tissues or organs from a donor's body to a recipient for replacing damaged tissues or organs. It includes transplantation of bones, tendons, skin grafts, heart, kidneys, liver, and others. The demand for transplantation is growing due to the rising prevalence of chronic diseases, trauma cases, and growing public awareness about organ donation.
The global tissue and organ transplantation market is estimated to be valued at US$ 20.8 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Protexin, and UAS Laboratories LLC. The key players are focusing on new product launches and mergers and acquisitions to expand their market share.
The growing demand for transplantation is driven by the increasing incidence of chronic diseases like cardiovascular diseases, cancer, diabetes, and neurological disorders. According to the estimates of World Health Organization, chronic diseases account for over 70% of all deaths worldwide. The growing prevalence of chronic illnesses has increased the demand for transplant procedures.
The Tissue And Organ Transplantation Market Share is expanding globally due to factors such as rising healthcare expenditure, growth of the pharmaceutical industry, and increasing public-private investments to modernize healthcare infrastructure. The markets in Asia Pacific and Middle East regions are growing at a rapid pace due to the rising healthcare standards, large patient pools, and government initiatives to promote organ donation in these regions.
Market Key Trends
The rising public awareness about organ donation through social media campaigns and initiatives by non-profit organizations has positively influenced the donation rates. Majority of the countries across the world are observing National Organ and Tissue Donation week or month to educate people about the benefits of organ donation and the urgent need to bridge the gap between organ demand and supply. The growing public support for organ donation is expected to drive the growth of the tissue and organ transplantation market during the forecast period.
Porter’s Analysis
Threat of new entrants: Low cost of investment and technology required.
Bargaining power of buyers: Tissue and Organ Transplantation services are crucial for buyers hence low bargaining power.
Bargaining power of suppliers: Suppliers are specialist players and differentiated suppliers hence moderate bargaining power.
Threat of new substitutes: No close substitutes available hence low threat.
Competitive rivalry: Intense competition between existing players to gain market share.
The tissue and organ transplantation market in North America accounted for the largest share in 2024. Strong healthcare infrastructure along with presence of major transplant centers, favorable reimbursement policies and awareness towards organ donation are driving the market in the region.
Asia Pacific region is expected to be the fastest growing market during the forecast period. Rapidly improving healthcare infrastructure coupled with increasing expenditure on healthcare, rising awareness about organ donation and transplantation are supporting the growth of tissue and organ transplantation market in emerging economies like India and China.
Get more insights on Tissue and Organ Transplantation Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
(https://www.linkedin.com/in/money-singh-590844163)
Comments
0 comment